| Prognostic utility of baseline neutrophil-to-lymphocyte ratio in patients receiving immune checkpoint inhibitors: a review and meta-analysis DB Sacdalan, JA Lucero, DL Sacdalan OncoTargets and therapy, 955-965, 2018 | 281 | 2018 |
| Treatment of cancer patients during the COVID-19 pandemic in the Philippines FI Ting, DB Sacdalan, HS Abarquez, AJ Uson ecancermedicalscience 14, 2020 | 16 | 2020 |
| The association between inflammation and immunosuppression: implications for ICI biomarker development DB Sacdalan, JA Lucero OncoTargets and therapy, 2053-2064, 2021 | 14 | 2021 |
| Fan-on-face therapy in relieving dyspnea of adult terminally ill cancer patients: a meta-analysis MJL Mendoza, FIL Ting, JPB Vergara, DBL Sacdalan, J Sandoval-Tan Asian Journal of Oncology 6 (02), 88-93, 2020 | 13 | 2020 |
| Medical oncology care amidst the COVID-19 pandemic at the National University Hospital in the Philippines MJL Mendoza, HNC Tan, ARB Hernandez, BCA Dala, DBL Sacdalan, ... ecancermedicalscience 14, 2020 | 11 | 2020 |
| Treatment outcomes of patients with colorectal cancer enrolled in a comprehensive benefits program of the national insurance system in the Philippines: data from the pilot site FIL Ting, DBL Sacdalan, MMT Tampo, RT Apellido, HJ Monroy III, ... JCO Global Oncology 6, 35-46, 2020 | 11 | 2020 |
| Revisiting a lower starting dose of alectinib in ALK-positive non-small cell lung cancer DB Sacdalan, JA Lucero Cancer Treatment and Research Communications 27, 100319, 2021 | 9 | 2021 |
| A systematic review and meta-analysis on the efficacy and safety of metformin as adjunctive therapy among women with metastatic breast cancer PMM Lusica, KPY Eugenio, DBL Sacdalan, CA Jimeno Cancer Treatment and Research Communications 29, 100457, 2021 | 7 | 2021 |
| Bevacizumab in metastatic small-bowel adenocarcinoma: A systematic review and meta-analysis JP Vergara, DBL Sacdalan, M Amurao-Amante, DL Sacdalan Rare Tumors 11, 2036361318825413, 2019 | 7 | 2019 |
| Cell-free DNA methylation-defined prognostic subgroups in small-cell lung cancer identified by leukocyte methylation subtraction SU Haq, S Schmid, MK Aparnathi, K Hueniken, LJ Zhan, D Sacdalan, ... Iscience 25 (12), 2022 | 6 | 2022 |
| Patterns of biomarker use in cancer treatment among medical oncologists in the Philippines LI Catedral, HN Tan, A Chua Jr, D Benedict Sacdalan, DL Sacdalan JCO Global Oncology 6, 1593-1608, 2020 | 6 | 2020 |
| Plasma cell-free tumor methylome as a biomarker in solid tumors: biology and applications DB Sacdalan, S Ul Haq, BH Lok Current Oncology 31 (1), 482-500, 2024 | 5 | 2024 |
| Clinicopathologic factors associated with mismatch repair status among Filipino patients with young-onset colorectal cancer DL Sacdalan, RL Garcia, MH Diwa, DB Sacdalan Cancer Management and Research, 2105-2115, 2021 | 5 | 2021 |
| Giant cell tumor of soft tissue of the nasopharynx: A case report EB Nepucpan, DB Sacdalan Cancer Treatment and Research Communications 23, 100171, 2020 | 5 | 2020 |
| Shared decision making at the general internal medicine outpatient clinic of the Philippine General Hospital: Patient’s perspective MJ Mendoza, DB Sacdalan, LA Palileo-Villanueva J Particip Med 8 (e14), 2016 | 5 | 2016 |
| The role of the medical oncologist in the holistic care of patients with cancer in the Philippines FI Ting, CD Uy, KG Bebero, DB Sacdalan, DL Sacdalan, HS Abarquez, ... ecancermedicalscience 15, 2021 | 4 | 2021 |
| Beyond bevacizumab: a review of targeted agents in metastatic small bowel adenocarcinoma DB Sacdalan, MJ Mendoza, JP Vergara, LI Catedral, FI Ting, LM Leones, ... Medical Oncology 37 (11), 106, 2020 | 4 | 2020 |
| What will keep me coming back to the clinic: Factors identified by Filipino colorectal cancer patients seen at a national academic referral center DB Sacdalan, JA Lucero, FI Ting, DL Sacdalan Journal of Patient Experience 7 (4), 460-463, 2020 | 4 | 2020 |
| Choosing Wisely Philippines: ten low-value or harmful practices that should be avoided in cancer care FI Ting, CD Uy, KG Bebero, DB Sacdalan, HS Abarquez, G Nilo, ... ecancermedicalscience 16, 2022 | 3 | 2022 |
| Updated general recommendations in cancer management during the COVID-19 pandemic in the Philippines FI Ting, MJ Mendoza, DB Sacdalan, HS Abarquez ecancermedicalscience 14, 2020 | 3 | 2020 |
Dennis Lee SacdalanClinical Associate Professor, University of the Philippines在 up.edu.ph 的电子邮件经过验证
